Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...

The FDA has approved a first-of-its-kind eye drop that addresses a common vision condition. The once-daily drops will treat an age-related condition that causes blurry near vision. The drops are ...

People with so-called "resting squint face" may seem like they are perpetually angry, but they may just be having trouble seeing. Focusing on close objects becomes increasingly difficult as people age ...

For millions of adults, aging brings a familiar frustration: difficulty focusing on close-up objects such as books, smartphones, or small print. Traditionally, reading glasses or surgery have been the ...

For people with age-related blurry vision, once-a-day prescription eye drops offer a quick fix that lasts for up to 10 hours. Vizz (aceclidine ophthalmic solution) eye drops received FDA approval for ...

Ultimately, the drops offer improved reading vision for up to 10 hours, without the need for glasses and, importantly, without the side effects of older treatments. In 2021, the very first drops to ...